Goldman Sachs’s Histogen Inc. Common Stock HSTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,567
Closed -$34K 6673
2021
Q2
$34K Buy
+1,567
New +$32.5K ﹤0.01% 6113
2019
Q3
Sell
-127
Closed -$7K 5467
2019
Q2
$7K Buy
127
+24
+23% +$4.17K ﹤0.01% 5088
2019
Q1
$22K Sell
103
-43
-29% -$17.3K ﹤0.01% 5048
2018
Q4
$51K Sell
146
-533
-78% -$414K ﹤0.01% 5092
2018
Q3
$788K Sell
679
-1,416
-68% -$1.3M ﹤0.01% 4181
2018
Q2
$1.79M Buy
2,095
+1,657
+378% +$1.38M ﹤0.01% 3696
2018
Q1
$514K Buy
438
+69
+19% +$76.3K ﹤0.01% 4477
2017
Q4
$341K Buy
369
+11
+3% +$10.2K ﹤0.01% 5102
2017
Q3
$393K Buy
358
+43
+14% +$48.9K ﹤0.01% 5280
2017
Q2
$363K Buy
315
+241
+326% +$293K ﹤0.01% 5351
2017
Q1
$86K Sell
74
-240
-76% -$232K ﹤0.01% 6119
2016
Q4
$331K Buy
314
+232
+283% +$105K ﹤0.01% 5405
2016
Q3
$33K Buy
82
+12
+17% +$4.89K ﹤0.01% 6614
2016
Q2
$29K Buy
+70
New +$34.3K ﹤0.01% 6603
2014
Q4
Sell
-99
Closed -$121K 7384
2014
Q3
$121K Buy
99
+3
+3% +$4.31K ﹤0.01% 6496
2014
Q2
$176K Sell
96
-4
-4% -$5.34K ﹤0.01% 6296
2014
Q1
$163K Sell
100
-10
-9% -$20.9K ﹤0.01% 6204
2013
Q4
$142K Sell
110
-98
-47% -$157K ﹤0.01% 6131
2013
Q3
$418K Buy
+208
New +$387K ﹤0.01% 5296

Other funds holding HSTO

Goldman Sachs's HSTO Position: Q3 2021 in Review

Goldman Sachs sold out of Histogen Inc. Common Stock (HSTO) in Q3 2021, closing a stake of 1,567 shares — an estimated $34K sold.

Goldman Sachs first reported a position in HSTO in Q3 2013 and held it in 19 quarters. The position peaked at $1.79M in Q2 2018. 22 funds tracked by Wall St. Rank hold HSTO as of Q3 2021.

  • Goldman Sachs reported no remaining Histogen Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Goldman Sachs sold 1,567 Histogen Inc. Common Stock shares in Q3 2021, an estimated $34K.
  • Goldman Sachs first reported a position in Histogen Inc. Common Stock in Q3 2013 and held it in 19 quarters.
  • Goldman Sachs's Histogen Inc. Common Stock position peaked at $1.79M in Q2 2018.
  • 22 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q3 2021.

Based on Goldman Sachs's 13F filing for Q3 2021, filed 10 Nov 2021.